Bictegravir/Lenacapavir sodium

N/A

Report date: 2026/04/30 20:00:20
NMEFirst In Class

Base Information

Drug NameBictegravir/Lenacapavir sodium
Drug Alias NameBIC/LENBictegravir/Lenacapavir
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV integrase inhibitorsCapsid protein inhibitors
TargetsHIV integraseCapsid protein
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[16] 
CombinationsYes BictegravirLenacapavir sodium
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEva PharmaGilead Sciences IncHetero Labs Ltd +[8] 
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A